Text Size

Recurrence of Acute Alcoholic Pancreatitis

This study has been completed.
Sponsor:
Information provided by:
University of Tampere
ClinicalTrials.gov Identifier:
NCT00523874
First received: August 31, 2007
Last updated: NA
Last verified: January 2001
History: No changes posted
  Purpose

Previously our retrospective study showed that almost half of the patients with acute alcoholic pancreatitis had a recurrent attack in the long-term, mild pancreatitis and young age being risk factors for recurrence. The aim of this prospective follow-up study was aimed to find out the risk factors in detail.


Condition
Recurrent Acute Pancreatitis

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Recurrence of Acute Alcoholic Pancreatitis

Resource links provided by NLM:

MedlinePlus related topics: Pancreatitis
U.S. FDA Resources

Further study details as provided by University of Tampere:

Enrollment: 120
Study Start Date: January 2001
Study Completion Date: May 2007
Detailed Description:

Patients admitted to Tampere University Hospital for first acute alcoholic pancreatitis were included. The diagnostic criteria for acute pancreatitis were epigastric pain, serum amylase > 3 x upper normal range, elevated serum CRP and signs of acute pancreatitis in imaging. Other etiologies were excluded. Alcohol consumption and dependency were detected. Serum and fecal markers of the endocrine and exocrine function and secretin stimulated MRCP were studied. The patients were followed median 38 (25 - 61) months for the recurrences and had a follow up visit at two years to investigate trends in the alcohol consumption.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who survived their first acute alcoholic pancreatitis. The diagnostic criteria for acute pancreatitis were epigastric pain, serum amylase > 3 x upper normal range, elevated serum CRP and signs of acute pancreatitis in imaging. Other etiologies were excluded.
  • High alcohol consumption was detected
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00523874

Locations
Finland
Tampere University Hospital
Tampere, Finland, 33521
Sponsors and Collaborators
University of Tampere
Investigators
Study Director: Isto Nordback, MD,dos Tampere University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00523874     History of Changes
Other Study ID Numbers: R00126
Study First Received: August 31, 2007
Last Updated: August 31, 2007
Health Authority: Finland: Ethical commettee of Federatio of Municipalities in the Hospital District of Pirkanmaa and National Authority for Medicolegal Affairs

Additional relevant MeSH terms:
Pancreatitis
Recurrence
Pancreatitis, Alcoholic
Pancreatic Diseases
Digestive System Diseases
 Disease Attributes
Pathologic Processes
Alcohol-Induced Disorders
Alcohol-Related Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on May 19, 2013